Export

ATC codes: H02AB06
EMLc
Indication
Allergic or hypersensitivity conditions of unspecified type ICD11 code: 4A8Z
INN
Prednisolone
Medicine type
Chemical agent
List type
Core
Formulations
Oral > Liquid: 5 mg per mL (EMLc)
Oral > Solid: 5 mg ; 25 mg
EML status history
First added in 1984 (TRS 722)
Changed in 2007 (TRS 950)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
Medicines within the same pharmacological class can be used
Patent information
Patents have expired in most jurisdictions
Summary of evidence and Expert Committee recommendations
Prednisolone was included in the core list of the first EMLc for this indication in 2007. The EMLc Subcommittee considered that allergic disorders (e.g., rhinitis, conjunctivitis, urticaria and contact dermatitis) are a common problem in children and therefore medicines for their treatment could be considered essential. In consideration of the need for corticosteroids for allergic disorders in children, the EMLc Subcommittee noted that prednisolone is licensed for 'steroid responsive conditions'. While recognizing the need for systemic steroids in severe allergic reactions, the Subcommittee noted that for conditions such as allergic rhinitis and conjunctivitis, topical steroids or topical antihistamines have been shown to be effective and safer.